Stakeholder Perspectives on Minimum Clinically Important Difference and Noninferiority Margin for Hospital-Free Days to Assess Interventions

Catherine L Auriemma; Maayra I Butt; Jasmine A Silvestri; Scott D Halpern; Katherine R Courtright

doi:10.1001/jamainternmed.2023.0918

Stakeholder Perspectives on Minimum Clinically Important Difference and Noninferiority Margin for Hospital-Free Days to Assess Interventions

JAMA Intern Med. 2023 Jul 1;183(7):739-742. doi: 10.1001/jamainternmed.2023.0918.

Authors

Catherine L Auriemma^{1

2

3}, Maayra I Butt¹, Jasmine A Silvestri¹, Scott D Halpern^{1

2

3}, Katherine R Courtright^{1

2

3}

Affiliations

¹ Palliative and Advanced Illness Research Center, University of Pennsylvania School of Medicine, Philadelphia.
² Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia.
³ Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.

PMID: 37252716
PMCID: PMC10230367 (available on 2024-05-30)
DOI: 10.1001/jamainternmed.2023.0918

No abstract available

Plain language summary

This survey study examined perceptions of patients, caregivers and health care professionals on the number of hospital-free days required for detection of a minimum clinically important difference or noninferiority margin of new interventions.

Stakeholder Perspectives on Minimum Clinically Important Difference and Noninferiority Margin for Hospital-Free Days to Assess Interventions

Authors

Affiliations

Plain language summary

Publication types

MeSH terms

Grants and funding